The current status of interferon-alpha treatment in advanced renal cancer.
Stebbing
J
J
The Department of Medicine, The Royal Marsden NHS Trust, London, UK.
Gore
M
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005544:Forecasting; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate
D000970:Antineoplastic Agents; D016898:Interferon-alpha